Clifford Chance advised Fresenius Kabi on the sale. German healthcare major Fresenius SE & Co. KGaA (FSNUF.PK, FSNPF.PK) announced that its operating company Fresenius Kabi transferred...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Banco Santander and its investment vehicle Moon GC&P Investments. Banco Santander and its investment vehicle Moon GC&P Investments completed the acquisition of a...
You must be a Standard 1 Year member to access this content.
Clifford Chance and KPMG acted for Ascendi on the deal. Ascendi, the Portuguese toll road operation platform owned by the French fund Ardian, proposed the acquisition of...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised healthcare group Fresenius and its Spanish subsidiary QuironSalud on the deal. Fresenius sells its 70% stake in IDCQ CRP, a co-holding entity of...
You must be a Standard 1 Year member to access this content.
Clifford Chance advises AltamarCAM Partners and its shareholders on Permira’s 40% stake investment. AltamarCAM Partners completed its agreement to sell a 40% stake in the company to...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Via Célere on the deal. Spanish residential property developer Via Célere announced the sale of 55% of its residential rental portfolio to...
You must be a Standard 1 Year member to access this content.
